Valuation: Medistim ASA

Market Cap 4.48B 472M 415M 390M 356M 666M 45.26B 671M 4.68B 1.82B 23.07B 1.77B 1.74B 74.81B P/E 2026 *
24.5x
P/E 2027 * 22.6x
Enterprise Value 4.34B 458M 402M 378M 345M 646M 43.87B 650M 4.54B 1.76B 22.37B 1.72B 1.68B 72.52B EV / Sales 2026 *
5.44x
EV / Sales 2027 * 4.98x
Free-Float
79.24%
Yield 2026 *
3.52%
Yield 2027 * 3.66%
1 day+1.22%
1 week+0.81%
Current month-3.12%
1 month-3.12%
3 months+8.30%
6 months+18.66%
Current year-4.25%
1 week 244
Extreme 244
253
1 month 240
Extreme 240
270
Current year 186.5
Extreme 186.5
270
1 year 186.5
Extreme 186.5
292
3 years 130
Extreme 130
292
5 years 130
Extreme 130
402.5
10 years 60
Extreme 60
409
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2009
Director of Finance/CFO - 01/01/2001
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Chairman 78 01/01/2000
Director/Board Member 49 01/01/2014
Director/Board Member 56 01/04/2023
Date Insider Type Main position Quantity % Market Cap. Importance
4/3/25 Buy

Chairman

860,735 4.6939%
27/1/25 Buy

Chairman

45,000 0.2454%
9/1/25 Buy

Chairman

30,000 0.1636%
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%+0.81%+6.44%+16.43% 472M
+2.09%+2.65%+44.39%+33.64% 246B
+1.93%+5.46%+20.54%-11.09% 156B
+0.63%+4.66%-9.59%+36.89% 141B
+0.75%+3.17%-54.18%-16.49% 64.66B
+0.05%-1.75%+16.13%+24.83% 50.04B
+0.13%-3.57%-20.20%-21.59% 47.18B
+4.06%+9.61%+37.77%+53.08% 46.61B
+3.45%+0.37%+47.37%+59.17% 41.32B
+4.13%+6.87%+177.54%+99.40% 38.56B
Average +1.76%+3.25%+26.62%+27.43% 83.13B
Weighted average by Cap. +1.70%+3.64%+23.68%+23.64%

Financials

2026 *2027 *
Net sales 798M 84.18M 73.88M 69.45M 63.49M 119M 8.06B 120M 834M 323M 4.11B 316M 309M 13.33B 868M 91.55M 80.36M 75.54M 69.06M 129M 8.77B 130M 907M 352M 4.47B 344M 336M 14.5B
Net income 182M 19.24M 16.89M 15.87M 14.51M 27.12M 1.84B 27.32M 191M 73.91M 940M 72.25M 70.66M 3.05B 203M 21.4M 18.78M 17.66M 16.14M 30.16M 2.05B 30.39M 212M 82.21M 1.05B 80.36M 78.6M 3.39B
Net Debt -138M -14.49M -12.72M -11.96M -10.93M -20.43M -1.39B -20.58M -144M -55.69M -708M -54.43M -53.24M -2.3B -158M -16.71M -14.67M -13.79M -12.6M -23.55M -1.6B -23.73M -166M -64.19M -816M -62.75M -61.37M -2.65B
Logo Medistim ASA
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Employees
159
Date Price Change Volume
24/09/26 NOK 248.00 +1.22% 25,492
23/09/26 NOK 245.00 -2.39% 9,288
22/09/26 NOK 251.00 +0.80% 15,395
21/09/26 NOK 249.00 +0.40% 14,555
18/09/26 NOK 248.00 +0.81% 20,334
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
245.00NOK
Average target price
332.50NOK
Spread / Average Target
+35.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDI Stock